Subscriber Authentication Point
lvrea
Home All issues Volume 25 / No 3 (Mai 2016) Réanimation, 25 3 (2016) 296-307 References
Free Access
Issue
Réanimation
Volume 25, Number 3, Mai 2016
Infectieux
Page(s) 296 - 307
Section Mise Au Point / Update
DOI https://doi.org/10.1007/s13546-016-1176-5
Published online 14 March 2016
  • Leroy O, Meybeck A, Sarraz-Bournet B, et al (2012) Vascular graft infections. Curr Opin Infect Dis 25:154–8 [CrossRef] [PubMed] [Google Scholar]
  • Fitzgerald SF, Kelly C, Humphreys H (2005) Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother 56:996–9 [CrossRef] [PubMed] [Google Scholar]
  • Haute Autorité de santé. Évaluation des implants de pontage. http://www.has-sante.fr/portail/jcms/c_1528392/fr/rapport-d-evaluation-des-implants-de-pontage [Google Scholar]
  • Haute Autorité de santé. Implant endovasculaire dit stent aortique, rénal, iliaque ou fémoral - Note de cadrage. http://www.has-sante.fr/portail/jcms/c_1777246/fr/implant-endovasculaire-dit-stent-aortique-renal-iliaque-ou-femoral-note-de-cadrage [Google Scholar]
  • Kitamura T, Morota T, Motomura N, et al (2005) Management of infected grafts and aneurysms of the aorta. Ann Vasc Surg 19:335–42 [CrossRef] [PubMed] [Google Scholar]
  • Kieffer E, Sabatier J, Plissonnier D, et al (2001) Prosthetic graft infection after descending thoracic/thoracoabdominal aortic aneurysmectomy: management with in situ arterial allografts. J Vasc Surg 33:671–8 [CrossRef] [PubMed] [Google Scholar]
  • Batt M, Jean-Baptiste E, O'Connor S, et al (2008) In-situ revascularisation for patients with aortic graft infection: a single centre experience with silver coated polyester grafts. Eur J Vasc Endovasc Surg 36:182–8 [CrossRef] [PubMed] [Google Scholar]
  • Bandyk DF, Novotney ML, Back MR, et al (2001) Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg 34:411–9 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, D'Elia P, Devos P, et al (2012) Risk factors for methicillin-resistant staphylococcal vascular graft infection in an 11-year cohort study. J Infect 64:441–42 [CrossRef] [PubMed] [Google Scholar]
  • Vogt PR, Brunner-La Rocca HP, Carrel T, et al (1998) Cryopreserved arterial allografts in the treatment of major vascular infection: a comparison with conventional surgical techniques. J Thorac Cardiovasc Surg 116:965–72 [CrossRef] [PubMed] [Google Scholar]
  • Fiorani P, Speziale F, Rizzo L, et al (1997) Long-term follow-up after in situ graft replacement in patients with aortofemoral graft infections. Eur J Vasc Endovasc Surg 14:111–49 [CrossRef] [PubMed] [Google Scholar]
  • Roy D, Grove DI (2000) Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts. J Infect 40:184–7 [CrossRef] [PubMed] [Google Scholar]
  • Postier RG, Green SL, Klein SR, et al (2004) Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients. Clin Ther 26:704–14 [CrossRef] [PubMed] [Google Scholar]
  • Vogt PR, Brunner-LaRocca HP, Lachat M, et al (2002) Technical details with the use of cryopreserved arterial allografts for aortic infection: influence on early and midterm mortality. J Vasc Surg 35:80–6 [CrossRef] [PubMed] [Google Scholar]
  • Revest M, Camou F, Senneville E, et al (2015) Medical treatment of prosthetic vascular graft infections: review of the literature and proposals of a working group. Int J Antimicrob Agents 46:254–65 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, Sarraz-Bournet B, D'Elia PV, et al (2012) Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Microbiol Infect 18:352–8 [CrossRef] [PubMed] [Google Scholar]
  • Habib G, Lancellotti P, Antunes MJ, et al (2015) 2015 ESC Guidelines for the management of infective endocarditis. Eur Heart J 36:3075–128 [CrossRef] [PubMed] [Google Scholar]
  • InVS. Résistance aux anti-infectieux, données par pathogène. [10/30/2015] (2015); http://www.invs.sante.fr/Dossiers-thematiques/Maladies-infectieuses/Resistance-aux-anti-infectieux/Donnees-par-pathogene [Google Scholar]
  • Cremniter J, Slassi A, Quincampoix JC, et al (2010) Decreased susceptibility to teicoplanin and vancomycin in coagulase-negative Staphylococci isolated from orthopedic-device-associated infections. J Clin Microbiol 48:1428–31 [CrossRef] [PubMed] [Google Scholar]
  • Liakopoulos A, Neocleous C, Klapsa D, et al (2009) A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis. J Antimicrob Chemother 64:206–7 [CrossRef] [PubMed] [Google Scholar]
  • Lodise TP, Patel N, Lomaestro BM, et al (2009) Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients. Clin Infect Dis 49:507–14 [CrossRef] [PubMed] [Google Scholar]
  • Patel N, Pai MP, Rodvold KA, Lomaestro B, et al (2011) Vancomycin: we can't get there from here. Clin Infect Dis 52:969–74 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, D'Elia P, Sarraz-Bournet B, et al (2014) Tolerability of high doses of daptomycin in the treatment of prosthetic vascular graft infection: a retrospective study. Infect Dis Ther 3:215–23 [CrossRef] [PubMed] [Google Scholar]
  • Miro JM, Entenza JM, Del Rio A, et al (2012) High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 56:4511–5 [CrossRef] [PubMed] [Google Scholar]
  • ANSM : notice fosfomycine. http://agence-rd.ansm.sante.fr/php/ecodex/frames.php?specid=63322018&typedoc=N&ref=N0188958.htm [Google Scholar]
  • Legout L, D’Elia P, Sarraz-Bournet B, et al (2014) Factors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin. BMC Infect Dis 14:228 [CrossRef] [PubMed] [Google Scholar]
  • ONERBA. Annual Report 2011–2012 (2014): http://www.onerba.org/IMG/pdf/onerba_rapport_2011_web.pdf [Google Scholar]
  • Nordmann P, Naas T, Poirel L (2011). Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:1791–8 [CrossRef] [PubMed] [Google Scholar]
  • Szczot M, Meybeck A, Legout L, et al (2011) Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect 62:204–11 [CrossRef] [PubMed] [Google Scholar]
  • Nagy E, Urban E, Nord CE, Bacteria ESGoARiA (2011) Antimicrobial susceptibility of Bacteroides fragilis group isolates in Europe: 20 years of experience. Clin Microbiol Infect 17:371–9 [Google Scholar]
  • Leon C, Ruiz-Santana S, Saavedra P, et al (2009) Usefulness of the “Candida score” for discriminating between Candida colonization and invasive candidiasis in non-neutropenic critically ill patients: a prospective multicenter study. Crit Care Med 37:1624–33 [CrossRef] [PubMed] [Google Scholar]
  • Pappas PG, Kauffman CA, Andes DR, et al (2015) Clinical practice guideline for the management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis doi: 10.1093/cid/civ933 [Google Scholar]
  • Hoiby N, Bjarnsholt T, Moser C, et al (2015) ESCMID guideline for the diagnosis and treatment of biofilm infections 2014. Clin Microbiol Infect 21:S1–S25 [CrossRef] [PubMed] [Google Scholar]
  • Legout L, D'Elia PV, Sarraz-Bournet B, et al (2012) Diagnosis and management of prosthetic vascular graft infections. Med Mal Infect 42 :102–9 [CrossRef] [PubMed] [Google Scholar]
  • Paul M, Zemer-Wassercug N, Talker O, et al (2011) Are all beta-lactams similarly effective in the treatment of methicillin-sensitive Staphylococcus aureus bacteraemia? Clin Microbiol Infect 17:1581–6 [CrossRef] [PubMed] [Google Scholar]
  • Bai AD, Showler A, Burry L, et al (2015) Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. J Antimicrob Chemother 70:1539–46 [CrossRef] [PubMed] [Google Scholar]
  • González C, Rubio M, Romero-Vivas J, et al (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29:1171–7 [CrossRef] [PubMed] [Google Scholar]
  • Forrest GN, Tamura K (2010) Rifampin combination therapy for non-mycobacterial infections. Clin Microbiol Rev 23:14–34 [CrossRef] [PubMed] [Google Scholar]
  • Van Hal SJ, Lodise TP, Paterson DL (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54:755–71 [CrossRef] [PubMed] [Google Scholar]
  • Jacob JT, Diaz Granados CA (2013) High vancomycin minimum inhibitory concentration and clinical outcomes in adults with methicillin-resistant Staphylococcus aureus infections: a meta-analysis. Int J Infect Dis 17: e93–e100 [CrossRef] [PubMed] [Google Scholar]
  • Liu C, Bayer A, Cosgrove SE, et al (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 52:285–92 [CrossRef] [PubMed] [Google Scholar]
  • La Plante KL, Woodmansee S (2009) Activities of daptomycin and vancomycin alone and in combination with rifampin and gentamicin against biofilm-forming methicillin-resistant Staphylococcus aureus isolates in an experimental model of endocarditis. Antimicrob Agents Chemother 53:3880–6 [CrossRef] [PubMed] [Google Scholar]
  • Raad I, Hanna H, Jiang Y, et al (2007) Comparative activities of daptomycin, linezolid, and tigecycline against catheter-related methicillin-resistant Staphylococcus bacteremic isolates embedded in biofilm. Antimicrob Agents Chemother 51:1656–60 [CrossRef] [PubMed] [Google Scholar]
  • Perrottet N, Steinrücken J, Chan M, et al (2015) Efficacy and safety of high-dose daptomycin (> 6 mg/kg) for complicated bone and joint infections and implant-associated infections caused by Gram positive bacteria. Int J Antimicrob Agents 46:480–2 [CrossRef] [PubMed] [Google Scholar]
  • Miró JM, Entenza JM, Del Río A, et al (2012) High-dose daptomycin plus fosfomycin is safe and effective in treating methicillin-susceptible and methicillin-resistant Staphylococcus aureus endocarditis. Antimicrob Agents Chemother 56:4511–5 [CrossRef] [PubMed] [Google Scholar]
  • Moore CL, Osaki-Kiyan P, Haque NZ, et al (2012) Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Clin Infect Dis 54:51–8 [CrossRef] [PubMed] [Google Scholar]
  • Corvec S, Furustrand Tafin U, Betrisey B, et al (2013) Activities of fosfomycin, tigecycline, colistin, and gentamicin against extended-spectrum-beta-lactamase-producing Escherichia coli in a foreign-body infection model. Antimicrob Agents Chemother 57:1421–7 [CrossRef] [PubMed] [Google Scholar]
  • Vasoo S, Cunningham SA, Cole NC, et al (2015) In vitro activities of ceftazidime-avibactam, aztreonam-avibactam, and a panel of older and contemporary antimicrobial agents against carbapenemase-producing Gram negative bacilli. Antimicrob Agents Chemother 59:7842–6 [CrossRef] [PubMed] [Google Scholar]
  • Maiolo EM, Furustrand Tafin U, Borens O, Trampuz A (2014) Activities of fluconazole, caspofungin, anidulafungin, and amphotericin B on planktonic and biofilm Candida species determined by microcalorimetry. Antimicrob Agents Chemother 58:2709–17 [CrossRef] [PubMed] [Google Scholar]
  • SPILF (2009) Recommandations de pratique clinique. Infections ostéoarticulaires sur matériel (prothèse, implant, ostéosynthèse). http://www.infectiologie.com/fr/recommandations.htm [Google Scholar]
  • Segreti J, Nelson JA, Trenholme GM (1998) Prolonged suppressive antibiotic therapy for infected orthopedic prostheses. Clin Infect Dis 27:711–3 [CrossRef] [PubMed] [Google Scholar]
  • Aukema TS, Legemate DA (2009) Gluteopopliteal bypass for a compromised groin. J Vasc Surg 49:483–5 [CrossRef] [PubMed] [Google Scholar]
  • Mertens RA, O'Hara PJ, Hertzer NR, et al (1995) Surgical management of infrainguinal arterial prosthetic graft infections: review of a thirty-five-year experience. J Vasc Surg 21:782–90 [CrossRef] [PubMed] [Google Scholar]
  • Murphy EH, Szeto WY, Herdrich BJ, et al (2013) The management of endograft infections following endovascular thoracic and abdominal aneurysm repair. J Vasc Surg 58:1179–85 [CrossRef] [PubMed] [Google Scholar]
  • Oderich GS, Bower TC, Cherry KJ, et al (2006) Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center. J Vasc Surg 43:1166–74 [CrossRef] [PubMed] [Google Scholar]
  • Jean-Baptiste E, Blanchemain N, Neut C, et al (2014) Evaluation of the anti-infectious properties of polyester vascular prostheses functionalised with cyclodextrin. J Infect 68:116–24 [CrossRef] [PubMed] [Google Scholar]
  • Topel I, Audebert F, Betz T, Steinbauer MG (2010) Microbial spectrum and primary resistance to rifampicin in infectious complications in vascular surgery: limits to the use of rifampicin-bonded prosthetic grafts. Angiology 61:423–6 [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.